Crossmark

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B

Crossref DOI link: https://doi.org/10.1038/nsmb.3344

Published Online: 2016-12-19

Published Print: 2017-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shi, Ke

Carpenter, Michael A

Banerjee, Surajit

Shaban, Nadine M

Kurahashi, Kayo

Salamango, Daniel J

McCann, Jennifer L

Starrett, Gabriel J

Duffy, Justin V

Demir, Özlem

Amaro, Rommie E

Harki, Daniel A

Harris, Reuben S

Aihara, Hideki
License Information

Text and Data Mining valid from 2016-12-19
More Information

Article History

Received: 11 October 2016

Accepted: 16 November 2016

First Online: 19 December 2016

Competing interests

: R.S.H. and D.A.H. are cofounders, shareholders, and consultants of ApoGen Biotechnologies Inc. H.A. and R.E.A. are consultants for ApoGen Biotechnologies Inc. R.E.A. is a cofounder of Actavalon Inc. The other authors declare no competing financial interests.